S017 The 2025 Debates: Controversies in Dermatology
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Evidence-based medicine is the conscientious and judicious use of the strongest current data in making decisions on how we care for our patients. Advances in technology, development of new therapies, and acquisition of new data challenge our best practices and may at the same time stimulate controversy. This session is designed for interactive discussion and critical thinking regarding some of the emerging issues that we are actively encountering in this current day.
LEARNING OBJECTIVES
Critically evaluate key issues and challenges in deploying molecular testing for the determination of melanoma risk and outcomes.
Define and recognize the current opportunities and challenges with developing and using Artificial Intelligence applications in dermatology.
Critically evaluate the key issues and challenges associated with melanoma (over)diagnosis and skin cancer screening.
SCHEDULE
6:00 PM
Introduction
Kenneth Y. Tsai, MD, PhD, FAAD
6:05 PM
Applications of Artificial Intelligence in Dermatology - Part 1
Yevgeniy Semenov, MD, MS, FAAD
6:25 PM
Applications of Artificial Intelligence in Dermatology - Part 2
Shannon Wongvibulsin, MD, PhD
6:45 PM
Open Discussion
Yevgeniy Semenov, MD, MS, FAAD, Shannon Wongvibulsin, MD, PhD
7:05 PM
The Clinical Utility of Molecular Testing in Melanoma and Keratinocyte Carcinomas - Part 1
Emily Y. Chu, MD, PhD, FAAD
7:25 PM
The Clinical Utility of Molecular Testing in Melanoma and Keratinocyte Carcinomas - Part 2
David Cotter, MD, PhD, FAAD
7:45 PM
Open Discussion
Emily Y. Chu, MD, PhD, FAAD, David Cotter, MD, PhD, FAAD
8:05 PM
The Challenges of Melanoma (Over)Diagnosis and Screening - Part 1
Adewole Shomari Adamson, MD, MPP, FAAD
8:25 PM
The Challenges of Melanoma (Over)Diagnosis and Screening - Part 2
David Polsky, MD, PhD, FAAD
8:45 PM
Open Discussion
Adewole Shomari Adamson, MD, MPP, FAAD, David Polsky, MD, PhD, FAAD
SPEAKERS
Adewole Shomari Adamson, MD, MPP, FAAD
Emily Y. Chu, MD, PhD, FAAD
David Cotter, MD, PhD, FAAD
David Polsky, MD, PhD, FAAD
Yevgeniy Semenov, MD, MS, FAAD
Kenneth Y. Tsai, MD, PhD, FAAD
Shannon Wongvibulsin, MD, PhD
SPEAKER DISCLOSURES
Adewole Shomari Adamson, MD, MPP, FAAD
No financial relationships exist with ineligible companies.
Emily Y. Chu, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
David Cotter, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees), Speaker(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Castle Biosciences – Investigator(Fees), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Dermavant Sciences, Inc. – Consultant (1099 relationship)(Honoraria); DermTech Inc. – Speaker(Honoraria); Galderma – Speaker(Honoraria); janssen – Advisory Board(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Novartis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
David Polsky, MD, PhD, FAAD
BMS – Independent Contractor(Grants/Research Funding); Medscape – Speaker(Honoraria); MoleSafe, Inc. – Other(Fees); Novartis – Independent Contractor(Grants/Research Funding); Viela Bio – Advisory Board(Stock);
Yevgeniy Semenov, MD, MS, FAAD
Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Journal of the American Academy of Dermatology – Other(Salary); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Kenneth Y. Tsai, MD, PhD, FAAD
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);
Shannon Wongvibulsin, MD, PhD
Sanofi/Regeneron – Advisory Board(Honoraria); VisualDx – Consultant (1099 relationship)(Honoraria);